Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension (NCT06911632)
MOMENTOUS Study (iMpact Of an Ecg ai ModEl oN The Diagnosis Of pUlmonary hypertenSion)
🩺 Plain-English Summary (8th-Grade Level)
MOMENTOUS is a multi-center, randomized study to prospectively evaluate the performance of an ECG-based AI device to predict whether participants with interstitial lung disease (ILD) are at high risk of undiagnosed pulmonary hypertension.
Who can join: Review the eligibility criteria below.
Location: University of Alabama at Birmingham — Birmingham, Alabama
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (32 Sites)
Showing the first 25 of 32 sites.
- University of Alabama at Birmingham — Birmingham, Alabama
- Banner University Medical Center — Phoenix, Arizona
- Dignity Health - St. Joseph's Hospital and Medical Center-Norton Thoracic Institute — Phoenix, Arizona
- National Jewish Health — Denver, Colorado
- AdventHealth Orlando — Orlando, Florida
- Northwestern University — Chicago, Illinois
- University of Illinois Health — Chicago, Illinois
- Indiana University Health Methodist Hospital — Indianapolis, Indiana
- Community Health Network — Indianapolis, Indiana
- University of Kentucky — Lexington, Kentucky
- Willis Knighton Health — Bossier City, Louisiana
- Louisiana State University Health Shreveport — Shreveport, Louisiana
- Brigham and Women's Hospital — Boston, Massachusetts
- University of Michigan - Michigan Medicine — Ann Arbor, Michigan
- University of Minnesota — Minneapolis, Minnesota
- University of Mississippi Medical Center — Jackson, Mississippi
- Hannibal Regional Healthcare System — Hannibal, Missouri
- CHI Health Creighton University Medical Center - Bergan Mercy — Omaha, Nebraska
- Renown Regional Medical Center — Reno, Nevada
- University of New Mexico — Albuquerque, New Mexico
- University of Buffalo — Buffalo, New York
- Southeastern Research Center — Winston-Salem, North Carolina
- University Hospitals Cleveland Medical Center — Cleveland, Ohio
- University of Oklahoma — Oklahoma City, Oklahoma
- Thomas Jefferson University — Philadelphia, Pennsylvania
📞 Contact the Study Coordinator
Phone: (833) 514-4187
Email: momentous-study@tempus.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Pulmonary Hypertension
- Trans-pulmonary Biomarkers in Pulmonary Hypertension — Nashville, Tennessee
- Activity Monitoring in Pulmonary Hypertension — Nashville, Tennessee
- LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF — Tucson, Arizona
- A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study) — Phoenix, Arizona
- A Study of Mosliciguat in PH-ILD — Phoenix, Arizona
- Frespaciguat (MK-5475) INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of Frespaciguat (an Inhaled sGC Stimulator) in Adults With PH-COPD — San Francisco, California
Explore by condition: All Pulmonary Hypertension clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.